Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1131096/000113109618000022/athn-20171231x10k.htm
February 2019
February 2019
January 2019
December 2018
December 2018
November 2018
November 2018
September 2018
July 2018
June 2018
• | 14% Revenue Growth Over Fourth Quarter of 2016 |
• | GAAP Operating Income of $38.7 million |
• | Non-GAAP Adjusted Operating Income of $77.6 million |
• | GAAP Net Income of $31.6 million, or $0.78 Per Diluted Share |
• | Non-GAAP Adjusted Net Income of $45.1 million, or $1.11 Per Diluted Share |
• | 13% Revenue Growth Over Full Year 2016 |
• | GAAP Operating Income of $70.6 million |
• | Non-GAAP Adjusted Operating Income of $175.0 million |
• | GAAP Net Income of $53.1 million, or $1.31 Per Diluted Share |
• | Non-GAAP Adjusted Net Income of $101.0 million, or $2.48 Per Diluted Share |
• | For the three months ended December 31, 2017, total revenue was $329.2 million, compared to $288.2 million in the same period last year, an increase of 14%. |
• | For the three months ended December 31, 2017, GAAP Gross Margin was 55.6%, compared to 53.7% in the same period last year. |
• | For the three months ended December 31, 2017, Service Automation Rate, formerly referred to as Non-GAAP Adjusted Gross Margin, was 68.0%, compared to 66.2% in the same period last year. |
• | For the three months ended December 31, 2017, GAAP Operating Income was $38.7 million, or 11.8% of total revenue, compared to $12.4 million, or 4.3% of total revenue, in the same period last year. |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1131096/000113109618000022/athn-20171231x10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Athenahealth Inc.
Athenahealth Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Rating
Learn More
Critical estimates in valuing certain intangible assets and the fair value of the reporting units during goodwill impairment tests include, but are not limited to, identifying reporting units, historical and projected client retention rates, anticipated growth in revenue from the acquired clients, expected future cash outflows, the allocation of those cash flows to identifiable intangible assets, estimated useful lives of these intangible assets, and a probability-weighted income approach based on scenarios in estimating achievement of operating results.
However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.
Compensation costs increased $25.5 million for the year ended December 31, 2017, largely due to a 9% increase in headcount, as well as an increase in expensed versus capitalized projects from the year ended December 31, 2016.
We used consultants in numerous capacities, including assistance in identifying significant cost-savings opportunities related to the Plan, temporarily staffing open positions, and assisting in our analysis and implementation of the new revenue recognition standard.
While we believe that our approach to estimates and judgments is reasonable, actual results could differ, and such differences could lead to an increase or decrease in expenses in the current period.
Compensation costs also includes a...Read more
Although we believe that our...Read more
For the foreseeable future, we...Read more
Selling and marketing expense primarily...Read more
The increase in business services...Read more
During 2017, we commenced a...Read more
We may increase the revolving...Read more
As a result, we expect...Read more
Research and development expense increased...Read more
We expect that, in the...Read more
Research and development expense increased...Read more
General and administrative expense increased...Read more
Net cash used in investing...Read more
This decrease was primarily due...Read more
Net cash provided by operating...Read more
Selling and marketing expense increased...Read more
Compensation costs increased $23.3 million...Read more
We expect that cost of...Read more
In addition, amortization expense increased...Read more
In general, our cost of...Read more
Significant judgments related to the...Read more
Business Combinations, including purchased intangible...Read more
Cost of revenue primarily consists...Read more
Therefore, the key drivers of...Read more
Net cash used in investing...Read more
In connection with the preparation...Read more
Total revenue for the year...Read more
The accounting estimates used in...Read more
The difference in our effective...Read more
The increase in net cash...Read more
Refer to Note 11 Income...Read more
In connection with the Plan,...Read more
We expect that general and...Read more
The increase in collections-based revenue...Read more
The difference between our effective...Read more
On December 22, 2017, President...Read more
Such gains and losses could...Read more
Business services revenue for athenahealth-branded...Read more
Total revenue for the year...Read more
These costs are recorded in...Read more
We hired additional sales personnel...Read more
Our cash balance increased in...Read more
Costs incurred during the application...Read more
Due to the new revenue...Read more
Our integrated services consist of...Read more
Management uses various assumptions when...Read more
Compensation costs increased $6.7 million...Read more
Net cash used in investing...Read more
As of December 31, 2017,...Read more
As of December 31, 2016,...Read more
Purchased Intangible Assets and Goodwill...Read more
Indefinite-lived intangible assets are reviewed...Read more
Testing finite-lived intangible assets for...Read more
General and administrative expense was...Read more
We believe that including our...Read more
Business services primarily consists of...Read more
Our clients typically purchase one-year...Read more
All revenue, other than certain...Read more
Costs related to the preliminary...Read more
The increase in non-cash and...Read more
General and administrative expense increased...Read more
Consulting expense increased $12.1 million...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Athenahealth Inc provided additional information to their SEC Filing as exhibits
CIK: 1131096
Form Type: 10-K Annual Report
Accession Number: 0001131096-18-000022
Submitted to the SEC: Thu Feb 01 2018 4:12:32 PM EST
Accepted by the SEC: Thu Feb 01 2018
Period: Sunday, December 31, 2017
Industry: Business Services